Bone marrow mesenchymal stem cells (MSCs) have the potential to be used in the cellular therapy of solid organs. However, tissue regeneration is limited by the death of transplanted cells. One of the main mechanisms of stem cell death in transplanted organs is through ischemia. In the present study, we sought to investigate whether a plant-derived antioxidant, berberine (BBR), could protect MSCs against MSCs apoptosis in a model of ischemia consisting of serum deprivation-and hypoxia-induced apoptosis in vitro. We also investigated the potential mechanism(s) that may mediate the action of berberine. We found that berberine significantly attenuated hypoxia-induced MSC apoptosis. Further study revealed that berberine could scavenger the reactive oxygen species (ROS), inhibit the c-jun NH(2)-terminal kinase (JNK), the loss of mitochondrial membrane potential and the release of cytochrome c (Cyt C) and caspase-3. In addition, we also showed that berberine could activate phosphoinositide-3 kinase (PI3K)/Akt and that pretreatment with PI3K/Akt inhibitors prevented berberineinduced inhibition of ROS, JNK and subsequent apoptosis, suggesting that the protective effects of berberine were PI3K/Akt-dependent. Taken together, these findings reveal that berberine protects against MSC apoptosis by preventing ROS-dependent and JNK-driven cell apoptosis in a PI3K/Akt-dependent manner. These data indicate that berberine is a promising anti-apoptotic agent for improving MSC survival during cell transplantation.
Their multi-lineage potential, ability to elude detection by the host immune system, immunomodulatory properties and ease of expansion in culture make MSCs particularly promising for cell therapy. Transplantation of MSCs has proven to be an effective treatment for tissue injuries, including myocardial infarction, 5) hind limb ischemia, 6) acute renal failure 7) and liver transplantation. 8) However, progress in stem cell therapy is hampered by the poor survival of the implanted cells. For example, transplantation of MSCs into an ischemic heart causes massive (99%) and rapid (Ͻ4 d) cell death.
9) The reasons for this high peritransplantation cell death rate are still unclear, but experiments in which rat neonatal cardiomyocytes that were engrafted into vascularized tissue survived better than cells transplanted into ischemic tissues suggests that some components of ischemia might affect the survival rates of the grafted cells. 10) Recently, by using a model of ischemia consisting of hypoxia and serum deprivation, studies have shown that ischemia might be responsible for the extensive cell death observed during the transplantation of MSCs. [11] [12] [13] These findings indicate that the protection of these cells from ischemia-induced apoptosis may be critical for improving the efficiency of cell therapy.
Hypoxic/ischemic conditions have long been recognized as important mediators or modulators of apoptosis since these conditions bring about the excessive production of reactive oxygen species (ROS). [14] [15] [16] ROS, such as superoxide anions and hydrogen peroxide, are generated in a variety of cells stimulated with cytokines, peptide growth factors, irradiation or inflammatory signals. 17) ROS can activate several mitogen-activated protein serine/threonine kinases (MAPKs), which transduce diverse extracellular stimuli (mitogenic growth factors, environmental stresses and proapoptotic agents) to the nucleus via kinase cascades in order to regulate a wide array of cellular processes. 18) Low levels of ROS are essential for cell proliferation and differentiation, while excessive ROS directly damage the cell membrane, DNA and protein, leading to the alteration or loss of cellular functions and causing the inhibition of proliferation and the induction of apoptosis. 19) Based on the strong evidence that ROS are involved in hypoxia-induced cell apoptosis, 20, 21) numerous antioxidants have been used to enhance cell survival. Among these antioxidants, significant attention has been given to natural products with established antioxidant activities and low cell toxicities, such as vitamin D, tea polyphenols and isoquinoline alkaloids. 22, 23) Berberine ([C 20 H 18 NO 4 ] ϩ , BBR), which is a natural isoquinoline alkaloid with a long history of use in Chinese medicine, has been isolated from a variety of medicinal plants such as Coptis chinensis, Berberis aquifolium and Berberis aristata. Berberine has been reported to possess various pharmacological effects including anti-cancer and anti-microbial effects, LDL-lowering effects and anti-inflammatory potential. [24] [25] [26] [27] Recent studies have shown that berberine exhibits antioxidative properties in several cell types, including smooth muscle cells, endothelial cells and mesangial cells. [28] [29] [30] In the present study, we created the in vitro model of ischemia consisting of hypoxia and serum deprivation to investigate the effects of berberine in hypoxia-induced MSC apoptosis. In addition, we attempted to elucidate the role of its downstream signals that mediate such actions. Our present study demonstrated for the first time that berberine protects MSCs from hypoxia-induced apoptosis and that berberine exerts its antiapoptotic effects via inhibiting the ROS-associated c-jun NH(2)-terminal kinase (JNK) pathway and activating the phosphoinositide-3 kinase (PI3K)/Akt pathway.
MATERIALS AND METHODS

Materials and Reagents
Berberine chloride (BBR), Nacetyl-L-cysteine (NAC) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma (St. Louis, MO, U.S.A.). Dulbecco's Modified Eagle's medium (DMEM)/Ham's F-12 and fetal bovine serum (FBS) were obtained from Gibco (NY, U.S.A.). The Mitochondria/Cytosol Fractionation Kit was from BioVision (Palo Alto, CA, U.S.A.). The antibodies against phosphorylated Akt (Ser473), Akt, phosphorylated JNK, JNK, cleaved caspase-3 and cytochrome c were purchased from Cell Signaling (Beverly, MA, U.S.A.). Wortmannin and LY294002 were from Calbiochem (San Diego).
Isolation and Culture of MSCs Bone marrow (BM) was obtained from male Sprague-Dawley rats weighing 180-200 g. BM from femurs and tibias was flushed with DMEM/F12 containing 10% inactivated FBS and 1% penicillin/streptomycin (Invitrogen, U.S.A.). Cells were then incubated at 37°C in a humidified tissue culture incubator containing 5% CO 2 and 95% air. Non-adherent cells were removed after 24 h and MSCs were recovered by their capacity to adhere to plastic culture dishes. MSCs were then routinely cultured and cells between the third and sixth passage were used in the experiments.
To evaluate MSC surface antigens, MSCs were incubated with mouse monoclonal anti-rat CD34 (Santa Cruz Biotechnology, CA, U.S.A.), anti-CD90, anti-11b, anti-CD29 (BioLegend, San Diego, CA, U.S.A.), anti-CD45 and anti-CD54 (Catag Laboratories, Burlingame, CA, U.S.A.). Fluorescence was analyzed by flow cytometry (Becton Dickinson, FACS Calibur).
In Vitro Model of MSC Hypoxia and Drug Treatment The in vitro hypoxia was produced as previously reported. 11, 13) Briefly, the cells were exposed to 5% CO 2 and 95% N 2 in an air-tight modular incubator chamber (BillupsRothenberg Inc., Del Mar, CA, U.S.A.) in the presence of serum-free DMEM/F12. Increasing concentrations of berberine were preincubated with MSCs for 1 h in complete medium before washing the cells in serum-free DMEM/F12 and reincubating them in the serum-free DMEM/F12 for 6 h in the continued presence of berberine under hypoxic conditions. For normoxic controls, cells were cultured in DMEM/F12 with 10% FBS (DMEM/F12/FBS) and were placed in a 37°C/5% CO 2 incubator for 6 h.
When used, 100 nM wortmannin or 25 mM LY294002 (PI3K/Akt inhibitors) was preincubated with cells in DMEM/F12/FBS for a period of 90 min before exposure to hypoxia. Berberine was added in the presence of each drug for 1 h prior to exposure to hypoxia. The cells were subsequently washed in serum-free DMEM/F12 and exposed to hypoxia in the continued presence of berberine and one of the inhibitors. Cells were pretreated for 1 h with the ROS scavenger NAC (500 mM) before hypoxia in DMEM/F12/FBS. Then, the cells were washed in serum-free DMEM/F12 and reincubated in DMEM/F12/FBS for 6 h in the continued presence of NAC under hypoxic conditions. Cell Viability Assay Cell viability was assessed using the MTT assay. MTT was converted by metabolically active cells to purple formazan. Cells were plated onto 96-well plates and exposed to hypoxia alone or pretreated with different concentrations of berberine for 1 h. After 6 h of hypoxia, 20 ml of MTT tetrazolium salt dissolved in Hank's balanced salt solution at a final concentration of 5 mg/ml was added to each well and incubated for 4 h. This product was then dissolved in isopropanol and quantified spectrophotometrically at a wavelength of 570 nm with a reference wavelength of 630 nm. The following formula was used to calculate cell viability: percentage cell viabilityϭ(absorbance of the experiment samples/absorbance of the control)ϫ100.
Detection of ROS Production Production of cellular ROS was evaluated by analyzing changes in fluorescence intensity resulting from the oxidation of the intracellular fluoroprobe 2Ј,7Ј-dichlorodihydrofluorescein diacetate (DCFH-DA). DCFH-DA (Sigma, U.S.A.) enters cells passively and is de-acetylated by esterase to the non-fluorescent dichlorodihydrofluorescein (DCFH). DCFH reacts with ROS to form dichlorofluorescein (DCF), a fluorescent product. DCFH-DA was dissolved in ethanol at 10 mM and was diluted 500-fold in DMEM/F12 to give DCFH-DA at 20 mM. Cells were exposed to DCFH-DA for 30 min and then exposed to hypoxia for 6 h after being treated with or without berberine or NAC. The fluorescence was read at an excitation wavelength of 488 nm and an emission wavelength of 530Ϯ20 nm. And the total green fluorescence intensities of every well were quantitated using image-analysis software (Simple PCI, Hamamatsu City, Japan). DCFH-DA was initially dissolved to 40-50 mM in ethanol and stored at Ϫ20°C. Ethanol (0.6% or less) did not alter the fluorescence measurement.
Morphological Assessment and Quantification of Apoptotic MSCs Hoechst 33342 Staining: To quantify apoptotic cells, cellular monolayers were fixed and stained with Hoechst 33342. The morphological features of apoptosis (cell shrinkage and chromatin condensation and fragmentation) were monitored via fluorescence microscopy (Olympus BX 60, Japan). At least 400 cells from 12 randomly selected fields per dish were counted, and each treatment was performed in triplicate.
Flow Cytometry: Cell apoptosis was estimated using the Annexin-V Fluorescein (FITC) apoptosis detection kit Detection of Mitochondrial Membrane Potential Loss of the mitochondrial membrane potential (DYm) was assessed using the fluorescent probe JC-1 (Molecular Probes, U.S.A.), which exists predominantly in the monomeric form in cells with depolarized mitochondria and fluorescences green at 490 nm. Cells with polarized mitochondria predominantly contained JC-1 in an aggregated form and fluorescenced reddish-orange. MSCs were incubated with 5 mM of JC-1 for 10 min at 37°C, washed and placed on a warmed microscope stage at 37°C. Fluorescent images were visualized with a Nikon Optical TE2000-S inverted fluorescence microscope with excitation at 490 nm and emission at 520 nm. The acquired signal was analyzed with image-analysis software (Simple PCI). The ratio of J-aggregate intensity to JC-1 monomer intensity for each region was calculated. A decrease in this ratio was interpreted as loss of DYm, whereas an increase in the ratio was interpreted as gain in DYm.
Western Blot Analysis Cells were washed twice with ice-cold PBS and homogenized in 200 ml of lysis buffer. After incubation for 20 min on ice, the cell lysates were centrifuged (10000ϫg for 10 min at 4°C) and the protein concentration in the extracts was determined using the Bradford assay. Proteins in cell extracts were denatured with SDS sample buffer and separated by 10% SDS-PAGE. Proteins were transferred to nitrocellulose membranes using a Bio-Rad miniprotein-III wet transfer unit. Nonspecific binding was blocked with 5% nonfat milk dissolved in TBST (pH 7.5, 10 mM Tris-HCl, 150 mM NaCl and 0.1% Tween-20) for 1 h at room temperature. The membranes were then incubated overnight at 4°C with individual primary antibodies including antibodies against anti-JNK, anti-phospho-JNK, anti-Akt and anti-phospho-Akt. Following three washes with TBST, the membranes were then incubated for 1 h at room temperature with horseradish peroxidase-conjugated secondary antibodies diluted in TBST containing 5% BSA. The membranes were then washed in triplicate with TBST and the protein bands were visualized with the ECL Western blotting detection system according to the manufacturer's instructions.
For the analysis of cytochrome c release from the mitochondria, we used the Mitochondria/Cytosol Fractionation Kit according to the manufacturer's protocols. Both the isolated mitochondrial and cytosolic fractions were subjected to Western blot analysis using a monoclonal cytochrome c antibody.
Statistical Analysis All values are expressed as meanϮS.E.M. Statistical analysis for multiple comparisons was performed by using the one-way ANOVA followed by the post hoc least significant difference test. The level of statistical significance was defined as pϽ0.05.
RESULTS
Characterization of MSCs
MSCs were generated from bone marrow (BM) by adhesion to tissue culture-coated plates in complete medium, and were separated from contaminating hematopoietic cells by the third passage when they were morphologically defined by a fibroblast-like appearance. Characterization by flow cytometric analysis showed that most adherent cells expressed CD90, CD29 and CD54 and were negative for CD45, CD34 and CD11/b (Fig.  1A) . These results are consistent with the well-established markers of BM derived MSCs. 8, 31) Berberine Protects against Hypoxia-Induced MSC Apoptosis MSCs were pretreated with increasing concentrations of berberine (0.1, 1, 10, 20, 50 mM) for 1 h and then exposed to hypoxia for 6 h in the continued presence of berberine. Cell viability was determined using the MTT assay. Among the evaluated concentrations of berberine in hypoxia-treated MSCs, berberine at a dose of 10 mM rescued cell viability by approximately 97% (Fig. 1B) , indicating that berberine at 10 mM almost completely reversed the apoptosis of MSCs. Berberine treatment alone had no impact on nonhypoxic MSCs. Based on this result, all subsequent experiments were performed with 10 mM berberine.
To further elucidate whether berberine can protect MSCs against hypoxia-induced apoptosis, MSC apoptosis was morphologically determined using Hoechst staining. As shown in Figs. 2A and B, untreated cells had a normal elongated MSC morphology with round and regular nuclei. In contrast, condensation and fragmentation of nuclei, characteristics of apoptotic cells, were evident in MSCs after 6 h of hypoxia. The results above were similar with the previous report. 13) However, treatment with berberine blocked MSC apoptosis because the cells maintained their elongated morphology and large nuclei.
Flow cytometry results further confirmed the anti-apoptotic effects of berberine on hypoxia-induced MSC apoptosis. As shown in Fig. 2C , compared with the control, the portion of annexin V ϩ /PI Ϫ cells increased from 5.46 to 31.03% after 6 h of hypoxia. These results were consistent with the previous report. tion of ROS ROS function as pivotal components in proapoptotic signaling cascades. 32) In our study, hypoxia potently induced a six-fold increase in ROS production in MSCs compared with untreated cells. Berberine demonstrated a significant inhibition of ROS production, as determined by the DCFH oxidation assay. Similar results were observed with the general ROS scavenger NAC (500 mM) (Figs.  3A, B) .
Furthermore, the flow cytometry assay showed that both berberine and NAC pretreatment for 1 h prior to hypoxia resulted in a significant decrease in cell apoptosis (Fig. 3C) , indicating that the mechanism by which berberine exerted a protective effect was similar to NAC. These data indicate that berberine confers its protective effects via decreasing ROS production.
Berberine Prevents JNK Activation Downstream of ROS Production An increase in ROS is associated with the activation of the redox-sensitive JNK signaling pathway. 18, 33) To investigate whether hypoxia-induced ROS production leads to the activation of JNK in MSCs, we determined the phosphorylation state of JNK in cells subjected to hypoxia. As shown in Fig. 4A , cells exposed to hypoxia experienced a rapid phosphorylation of JNK, with the peak lev- 1338 Vol. 32, No. 8
Fig. 2. Effects of BBR on Hypoxia-Induced Apoptosis in MSCs
MSCs were pretreated with BBR (10 mM) for 1 h and then exposed to hypoxia for 6 h in the continued presence of BBR. (A) Morphological changes were determined by using a phase-contrast microscope. (B) Apoptosis was visualized by measuring apoptotic nuclear condensation using fluorescence microscopy after Hoechst staining. (C) The rate of apoptosis was measured by flow cytometry analysis after staining with Annexin V-FITC and propidium iodide (PI). Necrotic cells were identified as V els of phospho-JNK occurring at 30 min. This indicated that the JNK signaling pathway is activated during hypoxic conditions. Pretreatment with berberine for 1 h prior to hypoxia led to a reduction of phospho-JNK (Fig. 4B) . Similarly, NAC treatment (500 mM) could also inhibit phospho-JNK. These results indicate that ROS production induced by hypoxia contributes to the activation of JNK, and berberine may inhibit hypoxia-induced JNK phosphorylation via the inhibition of ROS. Berberine Prevents Hypoxia-Induced Loss of Mitochondrial Membrane Potential and the Release of Proapoptotic Factors in MSCs Activation of JNK can initiate apoptosis via the mitochondrial pathway by inducing the loss of mitochondrial membrane potential (DYm), the release of cytochrome c and the activation of caspase-3. 34) In the present study, cells undergoing hypoxia for 6 h resulted in a loss of DYm (Fig. 5A) . Berberine (10 mM) prevented the loss of DYm, and similar results were seen with NAC treatment (500 mM).
Mitochondrial dysfunction provokes the release of cytochrome c from the mitochondria into the cytosol. 34) Western blot analysis revealed that exposure of MSCs to hypoxia induced a significant increase in cytosolic cytochrome c levels. This was accompanied by a parallel decrease of cytochrome c in the mitochondrial fraction. However, these changes were inhibited by both berberine and NAC (Fig. 5B ).
In addition, we found that treating MSCs with hypoxia leads to activation of the apoptotic factor caspase-3, and pretreatment with either berberine or NAC significantly depressed levels of activated (cleaved) caspase-3 (Fig. 5C) .
Berberine Activates the PI3K/Akt Signaling Pathway, Which Inhibits ROS and Subsequent JNK Activity in MSCs PI3K/Akt is a critical mediator of cell survival in response to stimulation by several factors. 35) We therefore investigated whether the anti-apoptotic effect of berberine was linked to the PI3K/Akt signaling pathway in MSCs exposed to hypoxia. Pretreatment with berberine led to a time-dependent phosphorylation of Akt, with the maximal level occurring at 15 min, and this phosphorylation was sustained for approximately 2 h (Fig. 6A) . Both LY294002 (25 mM) and wortmannin (100 nM) blocked Akt phosphorylation induced by berberine (Fig. 6B) . Analysis by flow cytometry revealed that the protective effects of berberine (10 mM) against hypoxia-induced MSC apoptosis were blocked by both LY294002 (25 mM) and wortmannin (100 nM) (Fig. 6C) . These results suggest that the PI3K/Akt pathway might be involved in the antiapoptotic effects of berberine on MSCs.
The above data demonstrate that both the PI3K/Akt inhibitors LY294002 and wortmannin abolished the protective effects of berberine, while berberine could prevent ROS production. We therefore investigated the relationship between PI3K/Akt and ROS. We inferred that the inhibition of ROS was a mechanism behind berberine-induced protection; otherwise these two species may represent two parallel pathways for cell survival. The present data showed that ROS reduction after berberine treatment was reversed in the presence of either LY294002 or wortmannin (Fig. 6D) , indicating that berberine-induced activation of PI3K/Akt regulates the production of ROS. Combined with the results from Fig. 6B , the above data suggest that berberine-induced activation of PI3K/Akt inhibits subsequent ROS production.
To further elucidate the relationship between PI3K/Akt and berberine-induced inhibition of apoptosis, we assessed JNK activity in the presence of the PI3K/Akt inhibitor. Interestingly, berberine-mediated inhibition of JNK was significantly reversed by blocking Akt (Fig. 6E) . This result demonstrates that PI3K/Akt plays a novel intermediary role in the berberine-induced inhibition of JNK in hypoxia-induced apoptosis.
DISCUSSION
Over the past decade, stem cells from adult BM have been exploited as therapeutic vectors in the treatment of a wide variety of diseases. 36) However, a high percentage of the donor cells die within hours after transplantation, thus compromising the optimal outcome of the procedure.
16) The hypoxic environment can induce apoptosis and may be respon- sible for the loss of engrafted MSCs both in vivo and in vitro. 11, 13, 36) Therefore, protecting MSCs against apoptosis in pro-apoptotic hypoxic conditions is critical for improving the efficiency of cell therapy.
The effects of numerous antioxidants have been tested in cells exposed to hypoxia, and these agents do have protective capabilities in some experimental models. 21) In the present study, we used the plant-derived antioxidant berberine to test its protective effects in a model of in vitro hypoxia-induced MSC apoptosis. Our study demonstrated that berberine markedly attenuated MSC apoptosis that was induced by hypoxia. We further found that berberine could prevent ROS production and the accumulation of the pro-apoptotic stress kinase JNK. Moreover, we demonstrated that berberine could prevent the loss of the mitochondrial membrane potential and the subsequent release of cytochrome c, suggesting that berberine exerts a potent antiapoptotic activity in MSCs by preventing ROS-triggered mitochondrial apoptotic pathways. We also tested whether the antiapoptotic PI3K/Akt pathway is involved in berberine-induced protection against MSC apoptosis. Our results suggest that activation of the PI3K/Akt pathway by berberine led to the suppression of ROS, with subsequent inhibition of the pro-apoptotic JNK pathway.
Under normal conditions, the mitochondria are main sources of ROS. Small amounts of ROS are constantly produced as a by-product of mitochondrial respiration and are necessary for cell survival and proliferation. During hypoxia, an imbalance between the formation of free radicals and their scavenging results in the overproduction of electrons. These electrons react with residual molecular oxygen, leading to ROS generation. 17, 19) ROS could result in a loss of mitochondrial transmembrane potential, the release of proapoptotic molecules and the initiation of caspase-dependent apoptosis. 32) Berberine, which has been recognized as an antioxidant in some experiments, decreased ROS production in some normal cells. 28, 30) However, berberine could also induce an increase of ROS in some cancer cell lines. 37, 38) In the current study, we observed an increase of ROS in hypoxia-treated MSCs. Berberine blocked the generation of ROS in hypoxia-treated MSCs, indicating that berberine may exert potent antiapoptotic activities by inhibiting the generation of ROS in MSCs. Accordingly, the antioxidant NAC could also prevent the hypoxia-induced decrease in viability of MSCs, further confirming our assumption that the berberine-induced decrease of ROS plays a critical role in its antiapoptotic activity. It is not clear why berberine has a different impact on ROS generation between normal and cancer cells. This could, however, be related to the notion that cancer cells and normal cells may have different resting levels of ROS and antioxidant capacities. 39) These dual effects on the redox status are also observed with several other natural products, such as cyanidin-3-glucoside 40) and b-phenylethyl isothiocyanate (PEITC), 41) indicating that these effects could be a shared feature in some biologically active natural products.
Intracellular ROS accumulation inactivates MAPK phosphatases (MKPs) by the oxidation of their catalytic cysteine. This leads to the sustained activation of JNK, which plays a central role in ROS-mediated cell apoptosis. 18) In the present study, MSCs treated with hypoxia rapidly phosphorylated JNK, indicating that the JNK signaling pathway is activated in MSCs exposed to hypoxia. Berberine could suppress the hypoxia-induced increase in phospho-JNK levels, and the general antioxidant NAC also inhibited JNK phosphorylation. Thus, the results in the present study demonstrate that berberine may exert its anti-apoptotic effects by suppressing the JNK apoptotic pathway, and that the decreased phosphorylation of JNK may be dependent on ROS suppression. Future work should be directed toward exploring these possibilities.
Phosphorylated JNK translocates from the cytosol to the mitochondria, where JNK triggers mitochondrial membrane depolarization, thereby facilitating the release of mitochondrial proapoptotic proteins (e.g., cytochrome c and Endo G) into the cytosol. The release of cytochrome c from the mitochondria is a key step in the initiation of caspase-dependent apoptotic pathways.
34) The present study demonstrated that hypoxia-induced apoptosis in MSCs through the mitochondrial apoptotic pathway via the loss of DYm, the release of cytochrome c and the activation of caspase-3, which is consistent with a previous study. 13) These processes were prevented by berberine, which inhibits hypoxia-induced mitochondria-dependent apoptosis by preventing the loss of DYm, the release of cytochrome c and the activation of caspase-3. These results indicated that berberine may exert its antiapoptotic effect by inhibiting the caspase-dependent apoptotic pathway.
The PI3K/Akt signaling pathway plays a pivotal role in many physiological processes including metabolism, development, cell cycle progression, migration and survival. 42) PI3K/Akt can prevent cell apoptosis by the phosphorylation and inactivation of pro-apoptotic factors such as Bad, caspase-9 and the FH transcription factors. 43) In the present study, we observed low levels of phosphorylated Akt in MSCs exposed to hypoxia, and berberine increased phosphoAkt levels. This suggests that berberine protects against MSC apoptosis through the PI3K/Akt signaling pathway. Furthermore, we found that the selective PI3K/Akt inhibitor, either LY294002 or wortmannin could block the protective effects of berberine. To our surprise, the prevention of ROS generation and JNK phosphorylation induced by berberine was also blocked by either LY294002 or wortmannin, suggesting that berberine-induced inhibition of ROS and JNK was PI3K/Akt dependent. These results were in accordance with previous reports indicating that the PI3K/Akt pathway could prevent the increase of intracellular ROS levels. 44, 45) Activation of the PI3K/Akt pathway led to increased p38b activity, and p38b then suppressed ROS, the pro-apoptotic molecule JNK and apoptosis. 44) Further studies are required to investigate the precise mechanisms of this process.
We propose a working model of how berberine protects MSCs from hypoxia-induced apoptosis, which is depicted in Fig. 7 . Upon the model of in vitro hypoxia, ROS are generated from the mitochondria. The increased ROS stimulate the activation of pro-apoptotic JNK. JNK then causes a loss of DYm, the release of cytochrome c and caspase-3 and subsequent apoptosis. However, pretreatment with the antioxidant berberine activates PI3K/Akt. The PI3K/Akt pathway leads to the suppression of ROS, with the subsequent inhibition of JNK and the mitochondrial apoptotic pathway.
In summary, the present investigation indicates that berberine salvages MSCs from apoptosis after exposure to hypoxia. Berberine appears to confer its beneficial effects via activating PI3K/Akt, inhibiting ROS-dependent JNK activation and abrogating the mitochondrial apoptotic pathway. These findings indicate that berberine is a promising antiapoptotic agent for improving MSC survival in cell transplantation. Additional research will be required to identify the precise mechanisms responsible for this phenomenon and to clarify the potential exploitation of the pro-survival characteristics of berberine on MSCs during in vivo cell transplantation. Vol. 32, No. 8 Upon the model of in vitro hypoxia, ROS are generated in the mitochondria. BBR may activate PI3K/Akt in hypoxia-treated MSCs. This activation of PI3K/Akt results in ROS and JNK suppression, and inhibits the decrease of DYm, the release of cytochrome c and caspase-3 and the subsequent apoptosis.
